desipramine has been researched along with Cyanosis in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomii, T | 1 |
| Honjo, O | 1 |
| Matsumoto, T | 1 |
| Tachibana, H | 1 |
| Fujii, Y | 1 |
| Ishino, K | 1 |
| Ogasawara, Y | 1 |
| Sano, S | 1 |
1 other study available for desipramine and Cyanosis
| Article | Year |
|---|---|
Impact of chronic cyanosis and reoxygenation on the microheterogeneity of the myocardial blood flow: digital radiographic study in neonatal rats.
Topics: Age Factors; Aging; Animals; Animals, Newborn; Chronic Disease; Coronary Circulation; Cyanosis; Desi | 2011 |